UPDATE 1-Roche lifts 2019 outlook after Q1 sales beat
April 17, 2019 at 01:38 AM EDT
Swiss drugmaker Roche raised its 2019 outlook after first-quarter sales rose 8 percent, beating analyst estimates on the strength of newer medicines including multiple sclerosis treatment Ocrevus and cancer immunotherapy Tecentriq.
